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Commonly used anesthetic isoflurane has been reported to promote Alzheimer’s disease
(AD) neuropathogenesis by inducing caspase-3 activation. However, the up-stream
mechanisms of isoflurane’s effects remain largely to be determined. Specifically, there
is a lack of a good model/system to elucidate the underlying mechanism of the
isoflurane-induced caspase-3 activation. We therefore set out to assess and compare
the effects of isoflurane on caspase-3 activation in neural progenitor cells (NPCs) and
in primary neurons from wild-type (WT) and AD transgenic (Tg) mice. The NPCs and
neurons were obtained, cultured and then treated with either 2% isoflurane or under
control condition for 6 h. The NPCs or neurons were harvested at the end of the
treatment and were subjected to Western blot analysis. Here we showed for the first
time that the isoflurane treatment induced caspase-3 activation in neurons, but not in
NPCs, from either WT or AD Tg mice. Consistently, the isoflurane treatment increased
cytosol levels of cytochrome c, a potential up-stream mechanism of isoflurane-induced
caspase-3 activation in the mice neurons, but not NPCs. Finally, the isoflurane treatment
induced a greater casapse-3 activation in the neurons, but not the NPCs, from AD Tg mice
as compared to the WT mice. These data demonstrated that investigation and comparison
of isoflurane’s effects between mice NPCs and neurons would serve as a model/system
to determine the underlying mechanism by which isoflurane induces caspase-3 activation.
These findings would promote more research to investigate the effects of anesthetics on
AD neuropathogenesis and the underlying mechanisms.
Keywords: Alzheimer’s disease, anesthesia, isoflurane, caspase-3, cytochrome c, neural progenitor cells,
neurons
INTRODUCTION
Alzheimer’s disease (AD) is one of the most common forms of
dementia. Early studies showed that the age of onset of AD was
inversely related to the cumulative exposure to general anesthesia
before the age of 50 (Bohnen et al., 1994b; Muravchick and
Smith, 1995). Lee et al. illustrated that patients having coro-
nary artery bypass graft surgery under general anesthesia were
at increased risk for the emergence of AD compared to those
having percutaneous transluminal coronary angioplasty under
local anesthesia (Lee et al., 2005). However, other studies showed
that there was no association between anesthesia/surgery and
AD (Bohnen et al., 1994a; Knopman et al., 2005; Avidan et al.,
2009; Sprung et al., 2013). Recently, Chen et al. analyzed the
claims data of 1 million insured residents covered by Taiwan’s
universal health insurance from 2005 to 2009 and found that
previous exposure to surgery under general anesthesia might be
associated with an increased risk of AD, particularly in patients
who had undergone repeated exposure to general anesthesia
(Chen et al., 2013a). Moreover, in a prospective and randomized
study of stable mild cognitive impairment patients, Liu et al.
found that patients who had sevoflurane anesthesia for surgery
showed a significantly faster progression of cognitive function
decline as compared to the patients who had epidural anesthe-
sia, propofol anesthesia, or no anesthesia (Liu et al., 2013). It
has been shown that there is a greater gray matter loss and
decline of cognitive function following anesthesia and surgery
as compared to an age-matched control cohort (Kline et al.,
2012). Finally, a retrospective study, including 24,901 patients
in the anesthesia/surgery group and 110,972 participants in the
control group, has demonstrated that patients who undergo
anesthesia and surgery may be at increased risk for dementia
(hazard ratio = 1.99; Chen et al., 2013b). Moreover, anesthesia
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and surgery have been reported to cause cognitive dysfunction,
which AD patients are susceptible to develop (Moller et al., 1998;
reviewed in Terrando et al., 2011; Eckenhoff and Planel, 2013).
Collectively, it is important to study whether anesthetics can
promote AD neuropathogenesis and investigate the underlying
mechanisms.
A recent study suggests that caspase-3 activation even with-
out apoptosis can contribute to AD neuropathogenesis (Bur-
guillos et al., 2011). The commonly used inhalation anesthetic
isoflurane has been shown to promote AD neuropathogene-
sis, including induction of caspase-3 activation and apoptosis
(Eckenhoff et al., 2004; Loop et al., 2005; Xie et al., 2006a, 2007,
2008; Wei et al., 2008; Zhang et al., 2010, 2012). However, the
underlying mechanism by which isoflurane induces caspase-3
activation still remains largely to be determined. Moreover, there
is a lack of a good model/system that can be used to deter-
mine the underlying mechanism(s) of the isoflurane-induced
caspase-3 activation. Neural progenitor cells (NPCs) may have
resistance to caspase-3 activation and apoptosis (Peng et al.,
2005). We therefore have hypothesized that isoflurane induces
caspase-3 activation in neurons but not in NPCs, and such a
difference can be used to establish a model/system to investigate
the underlying mechanism, e.g., cytosol cytochrome c levels, by
which isoflurane induces caspase-3 activation. We have utilized
NPCs and primary neurons from wild-type (WT) mice and AD
transgenic (Tg) mice [B6.Cg-Tg (APPswe, PSEN1dE9) 85Dbo/J].
The AD Tg mice have the same genetic background as the WT
mice (C57BL/6J) but with two mutant genes linked to familial
AD: APP and PSEN1 (Garcia-Alloza et al., 2006; Xiong et al.,
2011). It has been reported that another anesthetic, sevoflurane,
induces a greater caspase-3 activation in the brain tissues of
the young (6 day-old) AD Tg mice than that of WT mice (Lu
et al., 2010). Therefore, we used the AD Tg mice to determine
whether isoflurane could induce a greater caspase-3 activation
in the NPCs or neurons of the AD Tg mice than those of the
WT mice.
MATERIALS AND METHODS
MICE IN THE STUDIES
The animal protocol was approved by the Standing Committee
on Animals at Massachusetts General Hospital, Boston,
Massachusetts. WT mice (C57BL/6J, The Jackson Lab, Bar
Harbor, ME) and AD Tg mice [B6.Cg-Tg (APPswe, PSEN1dE9)
85Dbo/J (The Jackson Laboratory)] were used in the study. WT
and AD Tg mice were distinguished by genotyping.
“COMPLETE” PROLIFERATION MEDIA TO CULTURE NEURAL
PROGENITOR CELLS (NPCs)
Fifty ml NeuroCult™ neural stem cell proliferation supplements
(Stem Cell Technologies Inc., Vancouver, B.C., Canada) and
200 µg human epidermal growth factor (hEGF) (Stem Cell
Technologies Inc.) were added into 450 ml NeuroCult™ neural
stem cell basal media (Stem Cell Technologies Inc.) to a final
concentration of 400 ng/ml of hEGF, 100 units/ml penicillin, and
100 µg/ml streptomycin in the culture media.
HARVEST OF MICE NEURAL PROGENITOR CELLS (NPCs)
Harvest of mice NPCs was performed using our previous study
methods, with modifications (Zhang et al., 2013). Specifically,
18 or 19 day-gestation stage mice were euthanized with car-
bon dioxide. Embryos were extracted using cesarean section,
and then decapitated in a 100 mm dish of phosphate-buffered
saline (PBS). The heads were placed in a 100 mm dish and
the hippocampi were isolated. The hippocampi were put into
a 15 ml tube with 2.5 ml of “complete” proliferation media,
triturated 10–15 times using a 1000 µl plastic pipette tip, and
filtered through a 70 µm cell strainer to obtain the suspended
single NPCs. The NPCs were then suspended in 5 ml of “com-
plete” proliferation media and a cell count was taken with a
hemocytometer. One million cells were plated in each well of
a six-well plate containing 2.5 ml of “complete” proliferation
media. NPCs were passaged twice (every 7 days) before use. For
passaging the cells, media and cells were removed and placed
into a 50 ml centrifuge tube to remove adherent NPCs and
dead cells. Only non-adherent proliferating NPCs were collected.
The collected proliferating NPCs were centrifuged at 3000 rapid
per minute (rpm) for 5 min. The medium was removed and
the cells were re-suspended in 3 ml of “complete” proliferation
media. The cells were then triturated 10–15 times using a 1000 µl
plastic pipette tip and then plated at one million cells in 2.5 ml
of “complete” proliferation media in each well of a six-well
plate.
HARVEST OF MICE PRIMARY NEURONS
The mice primary neurons were harvested using the method
described in our previous studies with modifications (Zhen et al.,
2009; Zhang et al., 2010). Specifically, 15 day-gestation stage mice
were euthanized with carbon dioxide. Embryos were extracted
using cesarean section, and then decapitated in a 100 mm dish of
PBS. The heads were placed in a 100 mm dish and the hippocampi
were isolated. We collected the cortex, removed meninges, and
placed the tissues into 100-mm dish of PBS. The neurons were
dissociated by trypsinization and trituration then suspended in
5 ml of serum/neurobasal medium and a cell count was taken
with a hemocytometer. The amount of 0.3 million cells were
resuspended and plated into six-well plates containing 1.5 ml
of serum/neurobasal medium with a confluent rate of 50%.
After 1 h, the medium was changed to 1.5 ml per well serum-
free B27/neurobasal medium. The neurons were exposed to the
isoflurane treatment 6–8 days after the harvest.
TREATMENTS FOR NEURAL PROGENITOR CELLS (NPCs) AND NEURONS
The isoflurane treatment was performed as described in our
previous studies (Xie et al., 2006a, 2007, 2008; Zhang et al., 2010,
2012). Specifically, isoflurane was delivered from an anesthesia
machine to a sealed plastic box in a 37◦C incubator. The box
containing six-well plates seeded with one million NPCs or 0.25–
0.3 million neurons in 1.5 ml cell culture media. A Date infrared
gas analyzer (Ohmeda, Tewksbury, MA) was used to continuously
monitor the delivered concentrations of carbon dioxide, oxygen,
and isoflurane. The mice NPCs or neurons were treated with 2%
isoflurane plus 21% O2 and 5% CO2 or under control condition
for 6 h. The control condition was 21% O2 plus 5% CO2.
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IMMUNOFLUORESCENCE STAINING
The NPCs were washed with 3% bovine serum albumin (BSA)
in PBS twice, then the NPCs were permeabilized with 0.2%
Triton X-100 in PBS at 4◦C for 10 min, and blocked with 3%
BSA at room temperature for 1 h. NPCs were further incubated
with nestin antibody (1:200, Chemicon, Temecula, CA) overnight
at 4◦C, followed by staining with Alexa Fluor® 594 goat anti-
mouse IgG (Invitrogen, Carlsbad, CA) for 1 h at room temper-
ature and away from light. Finally, the cells were incubated with
4′, 6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI) in a
humidified dark chamber for 10 min, and then were analyzed in
mounting medium under a fluorescence microscope.
CELLULAR FRACTION
The cytochrome c levels in the cytosol were detected. We used
mitochondrial isolation kit (Pierce, Iselin, NJ) to isolate mito-
chondria from cytosol, which allowed us to exclusively detect
cytochrome c levels in cytosol. Specifically, the harvested neurons
or NPCs after the treatment with isoflurane or control condition
were placed in a 1.5 ml microcentrifuge tube, and each tube was
centrifuged at 850 g for 2 min. The supernatant was removed
and discarded from each tube. Then we added 400 µl of the
mitochondrial isolation reagent A into each tube. After 5 s of
vortex, the tubes were incubated on ice for 2 min. Then we
added 0.5 ml of the mitochondrial isolation reagent B into each
tube, and then they were put in a vortex at a maximum speed
for 5 s. We incubated the tubes on ice for 5 min before adding
400 µl of the mitochondrial isolation reagent C into each tube,
and they were centrifuged at 700 g for 10 min at 4◦C. We then
transferred the supernatant to a new 1.5 ml tube and centrifuged
each of these tubes at 3000 g for 15 min. Finally, we collected the
supernatant, which contained the cytosol fraction, and discarded
the pellet, which contained the isolated mitochondria. We used a
Spin-X UF 500 concentrator (Corning, Lowell, MA), which could
enhance the concentration of cytochrome c levels in cytosol for
the Western blot analysis.
CELL LYSIS AND PROTEIN AMOUNT QUANTIFICATION
The pellets of the harvested neurons and NPCs were detergent-
extracted on ice using an immunoprecipitation buffer (10 mM
Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 0.5% Nonidet
P-40) plus protease inhibitors (1 µg/ml aprotinin, 1 µg/ml leu-
peptin, 1 µg/ml pepstatin A). The lysates were collected, cen-
trifuged at 13,000 rpm for 15 min, and quantified for total protein
amount by a bicinchoninic acid protein assay kit (Pierce).
WESTERN BLOTS ANALYSIS
The harvested NPCs and neurons were subjected to Western
blot analyses as described in our previous studies (Zhang et al.,
2010, 2012). Specifically, a caspase-3 antibody (1:1000 dilution;
Cell Signaling Technology, Danvers, MA) was used to recognize
full-length caspase-3 (35–40 kDa) and caspase-3 fragment (17–
20 kDa) resulting from cleavage at aspartate position 175. Rabbit
polyclonal cytochrome c antibody (1:1000 dilution; Cell Signal-
ing Technology) was used to recognize cytochrome c (14 kDa).
Antibody anti-β-Actin (1:10,000, Sigma, St. Louis, MO) was
used to detect β-Actin (42 kDa). Each band in the Western blot
represented an independent experiment. The results were aver-
aged from three to five independent experiments. The intensity
of signals was analyzed using the National Institute of Health
image program. We quantified the Western blots in two steps.
First, we used β-Actin levels to normalize protein levels (e.g.,
determining the ratio of caspase-3 fragment to β-Actin amount)
and to control for loading differences in the total protein amount.
Second, we presented protein level changes in neurons or NPCs
having anesthesia as a percentage of those in the control group.
100% of protein level changes refer to control levels for the
purpose of comparison to experimental conditions.
STATISTICS
Given the presence of background caspase-3 activation in cells, we
did not use absolute values to describe these changes. Instead, the
caspase-3 activation was presented as a percentage of that of the
control group. Data were expressed as mean± standard deviation
(SD). The number of samples varied from three to five. Student
t-test was used to analyze the difference between control condi-
tion and isoflurane treatment on caspase-3 activation and levels
of cytosol cytochrome c. P-values less than 0.05 was considered
statistically significant. Prism 6 software (La Jolla, CA) was used
to analyze the data.
RESULTS
We aimed to establish a model/system in mice NPCs and mice
neurons, which could be used to determine the up-stream mech-
anisms of isoflurane-induced caspase-3 activation. First, we iden-
tified the mice NPCs by using immunofluorescence staining of
neurospheres with nestin (Figure 1).
ISOFLURANE INDUCED CASPASE-3 ACTIVATION IN MICE NEURONS
BUT NOT IN MICE NEURAL PROGENITOR CELLS (NPCs)
After identification of NPCs, we then determined and compared
the effects of isoflurane on caspase-3 activation in NPCs and
neurons from WT mice. Immunoblotting of caspase-3 showed
that the isoflurane treatment (2% isoflurane for 6 h, lanes 4–6)
did not induce caspase-3 activation, as evidenced by the increased
ratio of caspase-3 fragment to full-length (FL) caspase-3, com-
pared with the control condition (lanes 1–3) in the NPCs from
WT mice (Figure 2A). However, the same isoflurane treatment
(lanes 10–12) induced caspase-3 activation as compared to the
control condition (lanes 7–9) in the neurons from the WT mice
(Figure 2A). The quantification of the Western blot showed that
the isoflurane treatment (black bar) did not induce caspase-3 acti-
vation as compared to control condition (white bar) in WT mice
NPCs: 83% versus 100%, P = 0.439, N.S. (Figure 2B). In the WT
mice neurons, the quantification of the Western blot showed that
the isoflurane treatment (black bar) induced caspase-3 activation
as compared to control condition (white bar): 250% versus 100%,
∗∗ P = 0.001 (Figure 2C). These data suggested that whereas
isoflurane was able to induce caspase-3 activation in WT mice
neurons, the isoflurane treatment was not able to induce caspase-
3 activation in WT mice NPCs.
Our previous studies showed that sevoflurane, another com-
monly used inhalation anesthetic, induced a greater caspase-3
activation in the brain tissues of 6 day-old AD Tg mice than
Frontiers in Cellular Neuroscience www.frontiersin.org January 2014 | Volume 8 | Article 14 | 3
Zhang et al. Isoflurane, neural progenitor cells, neurons
FIGURE 1 | Identification of the mouse NPCs. Photomicrographs of
hippocampus NPCs grown in the “complete” proliferation culture media.
(A) Phase contrast photograph taken before fixation of a floating
neurosphere grown in a six-well plate. (B) Immunofluorescence image of a
neurosphere that was fixed and expressed nestin (the marker of NPCs,
green), DAPI (the marker of nuclei, blue), and merged image of a
neurosphere plated on FluoroDish. NPCs, neural progenitor cells; DAPI, 4’,
6-Diamidino-2-Phenylindole, Dihydrochloride.
that of 6 day-old WT mice (Lu et al., 2010). We therefore asked
whether isoflurane could induce caspase-3 activation in AD Tg
mice NPCs. Immunoblotting of caspase-3 showed that isoflurane
treatment (2% isoflurane for 6 h, lanes 4–6) did not induce
caspase-3 activation as compared to control condition (lanes 1–3)
in the AD Tg mice NPCs (Figure 2D). In the AD Tg mice neurons,
however, the isoflurane treatment (lanes 10–12) induced caspase-
3 activation as compared to the control condition (lanes 7–9)
(Figure 2D). The quantification of the Western blot showed that
the isoflurane treatment (black bar) did not induce caspase-3
activation as compared to the control condition (white bar) in the
AD Tg mice NPCs: 96% versus 100%, P = 0.179, N.S. (Figure 2E).
In the AD Tg mice neurons, however, the quantification of the
Western blot showed that the isoflurane treatment (black bar)
induced caspase-3 activation as compared to control condition
(white bar): 270% versus 100%, ∗∗ P = 0.003 (Figure 2F). These
data further suggested that isoflurane had different effects on
caspase-3 activation in the NPCs and neurons from both WT and
AD Tg mice.
Our previous studies have shown that anesthetic sevoflurane
induces a greater caspase-3 activation in the brain tissues of
AD Tg mice (Lu et al., 2010). We therefore asked whether
isoflurane could also induce a greater caspase-3 activation in
the NPCs and neurons of AD Tg mice than those of WT
mice by using a side-by-side comparison of isoflurane’s effects
on caspase-3 activation between NPCs and neurons of WT or
AD Tg mice. The caspase-3 immunoblotting showed that the
isoflurane treatment (lane 6, WT mice neurons, lane 8, AD
Tg mice neurons) induced caspase-3 activation as compared
to control condition (lane 5, WT mice neurons, lane 7 AD
Tg mice neurons) (Figure 2G). Moreover, the isoflurane treat-
ment induced a greater caspase-3 activation in AD Tg neurons
than that in WT neurons: lane 8 versus lane 6 (Figure 2G).
However, the isoflurane treatment did not cause a difference
in caspase-3 activation between WT mice NPCs and AD Tg
mice NPCs (Figure 2G). These data suggested that isoflurane
induced a greater caspase-3 activation in AD Tg mice neurons
than WT mice neurons. However, even in the NPCs from the
AD Tg mice, the isoflurane treatment did not induce caspase-3
activation.
ISOFLURANE INCREASED CYTOSOL CYTOCHROME C LEVELS IN MICE
NEURONS BUT NOT IN MICE NEURAL PROGENITOR CELLS (NPCs)
The findings that isoflurane induced caspase-3 activation in
mice neurons but not in mice NPCs suggested that the com-
parison of isoflurane’s effects between mice neurons and mice
NPCs could be used to determine the underlying mechanisms
of isoflurane’s neurotoxicity. Our previous studies have shown
that treatment with 2% isoflurane for 6 h induces caspase-3
activation and increases cytosol levels of cytochrome c in H4
human neuroglioma cells (Zhang et al., 2010). However, whether
the isoflurane-induced caspase-3 activation is associated with the
isoflurane-induced elevation of cytosol cytochrome c is unknown.
Therefore, we investigated and compared the effects of isoflurane
on cytosol cytochrome c levels between mice NPCs and mice
neurons. The immunoblotting of cytochrome c showed that there
was no visible difference in the cytosol levels of cytochrome
c between control condition (lane 1 or 3 of Figure 3A) and
isoflurane treatment (lane 2 or 4, Figure 3A) in either WT mice
NPCs (lanes 1 and 2) or AD Tg mice NPCs (lanes 3 and 4)
(Figure 3A). The quantification of the Western blot showed that
the isoflurane treatment did not increase the cytosol levels of
cytochrome c in WT mice NPCs (Figure 3B) and in AD Tg
mice NPCs (Figure 3C). In the WT mice neurons, however,
the immunoblotting of cytochrome c showed that the isoflu-
rane treatment (lane 2, Figure 3D) induced a visible increase in
the band of cytosol cytochrome c as compared to the control
condition (lane 1, Figure 3D). Moreover, in the AD Tg mice
neurons, the cytochrome c immunoblotting showed that the
isoflurane treatment (lane 4, Figure 3D) induced a visible increase
in the band of cytosol cytochrome c as compared to control
condition (lane 3, Figure 3D). The quantification of the Western
blot showed that the isoflurane treatment (black bar) increased
the cytosol levels of cytochrome c as compared to the control
condition (white bar) in WT mice neurons (Figure 3E): 140%
versus 100%, ∗ P = 0.025; and in AD Tg mice neurons (Figure 3F):
143% versus 100%, ∗∗ P = 0.003. These data suggested that
isoflurane only increased cytosol cytochrome c levels in mice
neurons but not in mice NPCs.
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FIGURE 2 | Isoflurane induces caspase-3 activation in mice neurons but
not in mice NPCs. (A) There is no visible difference in the caspase-3
activation (defined as the ratio of caspase-3 fragment to full-length
caspase-3) between the control condition (lanes 1–3) and the isoflurane
treatment (lanes 4–6) in the WT mice NPCs. There is a visible increase in the
caspase-3 fragment following the isoflurane treatment (lanes 10–12) as
compared to that following control condition (lanes 7–9) in the WT mice
neurons. (B) The quantification of the Western blot shows that the isoflurane
treatment (black bar) does not induce caspase-3 activation as compared to
control condition (white bar) in the WT mice NPCs. (C) The quantification of
the Western blot shows that the isoflurane treatment (black bar) induces
caspase-3 activation as compared to the control condition (white bar) in WT
mice neurons. (D) There is no visible difference in the caspase-3 activation
(defined as the ratio of caspase-3 fragment to full-length caspase-3) between
the control condition (lanes 1–3) and the isoflurane treatment (lanes 4–6) in
the AD Tg mice NPCs. There is a visible increase in the caspase-3 fragment
following the isoflurane treatment (lanes 10–12) as compared to that
following control condition (lanes 7–9) in the AD Tg mice neurons. (E) The
quantification of the Western blot shows that the isoflurane treatment (black
bar) does not induce caspase-3 activation as compared to control condition
(white bar) in the AD Tg mice NPCs. (F) The quantification of the Western
blot shows that the isoflurane treatment (black bar) induces caspase-3
activation as compared to the control condition (white bar) in AD Tg mice
neurons. (G) There is a higher level of caspae-3 fragment following the
isoflurane treatment (lane 6 or 8) than that following control condition (lane 5
or 7) in the WT or AD Tg mice neurons. The caspase-3 fragment level
following the isoflurane treatment in the AD Tg mice neurons (lane 8) is
greater than that in the WT mice neurons (lane 6). There is no visible
difference in the levels of caspase-3 fragment between control condition and
isoflurane treatment in the WT mice NPCs or AD Tg mice NPCs (lanes 1–4).
NPCs, neural progenitor cells; AD, Alzheimer’s disease; Tg, transgenic; WT,
wild type; full-length, FL.
DISCUSSION
The objective of the current study was to establish a model/system
to determine the underlying mechanism by which isoflurane, a
commonly used inhalation anesthetic, induces caspase-3 activa-
tion. We found that the treatment with 2% isoflurane for 6 h
was able to induce caspase-3 activation in WT mice neurons,
but not in WT mice NPCs (Figure 2). These results suggested
that the difference in caspase-3 activation following the isoflurane
treatment between mice NPCs and neurons could serve as a
model/system to determine the up-stream mechanisms of the
isoflurane-induced caspase-3 activation.
Our previous studies have shown that isoflurane can induce
caspase-3 activation and elevate the cytosol cytochrome c levels
in H4 human neuroglioma cells (Zhang et al., 2010). However,
whether the isoflurane-induced caspase-3 activation is associated
with the isoflurane-induced elevation of cytosol cytochrome c
levels remains unknown, owing to the lack of a model/system
to perform such studies. In the current experiments, we found
that the isoflurane treatment induced neither caspase-3 activation
nor elevation of cytosol cytochrome c levels in WT mice NPCs
(Figures 2 and 3). On the other hand, the isoflurane treat-
ment induced caspase-3 activation as well as elevation of cytosol
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FIGURE 3 | Isoflurane increases cytochrome c levels in mice neurons
but not in mice NPCs.(A) There is no visible difference in the cytosol
cytochrome c levels between the control condition (lane 1) and the
isoflurane treatment (lane 2) in the WT mice NPCs. There is no visible
difference in the cytochrome c levels between the control condition (lane
3) and the isoflurane treatment (lane 4) in the AD Tg mice NPCs. (B) The
quantification of the Western blot shows that the isoflurane treatment
(black bar) does not increase cytosol cytochrome c level as compared to
control condition (white bar) in the WT mice NPCs. (C) The quantification
of the Western blot shows that the isoflurane treatment (black bar) does
not increase cytosol cytochrome c levels as compared to the control
condition (white bar) in AD Tg mice NPCs. (D) There is a visible increase in
the cytosol cytochrome c levels following the treatment of isoflurane (lane
2) as compared to that following the control condition (lane 1) in the WT
mice neurons. There is a visible increase in the cytosol cytochrome c
levels following the treatment of isoflurane (lane 4) as compared to that
following the control condition (lane 3) in the AD Tg mice neurons. (E) The
quantification of the Western blot shows that the isoflurane treatment
(black bar) increases cytosol cytochrome c levels as compared to control
condition (white bar) in the WT mice neurons. (F) The quantification of the
Western blot shows that the isoflurane treatment (black bar) increases
cytosol cytochrome c levels as compared to the control condition (white
bar) in the AD Tg mice neurons. NPCs, neural progenitor cells; AD,
Alzheimer’s disease; Tg, transgenic; WT, wild-type.
cytochrome c levels in WT mice neurons (Figures 2 and 3).
Taken together, these data suggested that the isoflurane-induced
caspase-3 activation was associated with the isoflurane-induced
elevation of cytosol cytochrome c levels.
More importantly, these findings demonstrated that we have
established a model/system in NPCs and neurons, and we would
be able to use the established model/system to further determine
the up-stream mechanisms of the isoflurane-induced caspase-
3 activation in the future. Our previous studies suggested that
isoflurane might induce mitochondrial dysfunction, including
accumulation of reactive oxygen species and opening of mito-
chondrial permeability transition pore, leading to caspase-3 acti-
vation (Zhang et al., 2012). Thus, our future studies would further
test this hypothesis by determining and comparing the effects
of isoflurane on the accumulation of reactive oxygen species
and opening of the mitochondrial permeability transition pore
between mice NPCs and mice neurons.
Mutations of APP and PSEN1 gene may increase the vulnera-
bility to anesthetic (Lu et al., 2010). Consistently, we found that
isoflurane induced a greater caspase-3 activation in the neurons
harvested from the AD Tg mice with mutation of AD associated
genes APP and PSEN1 than that in neurons harvested from
WT mice in the current studies (Figure 2G). We also found
that the isoflurane treatment did not induce caspase-3 activation
and elevation of cytosol cytochrome c levels even in the NPCs
from AD Tg mice (Figures 2D; and 3A). Collectively, these data
suggested that although the mutation of APP and PSEN1 in neu-
rons enhanced the vulnerability of isoflurane-induced caspase-3
activation in mice neurons, the mutation did not increase the
vulnerability of the isoflurane-induced caspase-3 activation and
elevation of cytosol cytochrome c levels in mice NPCs.
Isoflurane may induce caspase-3 activation via up-stream
mechanisms other than mitochondria, which can also be assessed
in our established model/system. Using human fetal cortical
neural progenitor cells, Peng et al. have found that tumor
necrosis factor-related apoptosis-inducing ligand receptor 2 is
highly expressed on human NPCs derived from fetal cortex. The
inhibitors of apoptosis proteins are also highly expressed in the
human NPCs. Finally, cellular inhibitors of apoptosis protein
may protect NPCs against apoptosis and caspase-3 activation
(Peng et al., 2005). These findings suggest that isoflurane may
also induce caspase-3 activation by affecting the tumor necrosis
Frontiers in Cellular Neuroscience www.frontiersin.org January 2014 | Volume 8 | Article 14 | 6
Zhang et al. Isoflurane, neural progenitor cells, neurons
factor-related apoptosis-inducing ligand receptor 2 and/or the
cellular inhibitors of apoptosis protein. Future studies to test the
hypothesis in our established model/system of mice NPCs and
neurons are warranted.
There are several limitations in the current studies. First, we
did not assess the levels of total cytochrome c or other internal
controls in the studies, and we did not compare the effects
of isoflurane on other mitochondrial functions, e.g., levels of
reactive oxygen species, opening of mitochondrial permeability
transition pore, mitochondrial membrane potential, between
mice NPCs and neurons. However, the objective of the cur-
rent studies was to establish a model/system. The established
model/system will allow us to systematically determine and
compare the effects of isoflurane on cellular function between
NPCs and neurons, which will likely facilitates the elucidation of
the up-stream mechanism by which isoflurane induces caspase-
3 activation. Second, we did not compare the change of the
amount of cytochrome c levels inside the mitochondria. This is
because our previous studies have illustrated that there could
be minimal changes in the mitochondrial cytochrome c level
following isoflurane treatment in H4 human neuroglioma cells
(Zhang et al., 2010). Third, we did not investigate the effects
of different concentrations of isoflurane on caspase-3 activation
in the studies. This is mainly because our previous studies have
shown that treatment with 2%, but not 1%, isoflurane for 6,
but not 3 h is able to induce caspase-3 activation in cultured
cells and neurons (Xie et al., 2006a,b; Zhen et al., 2009). Finally,
there is currently no satisfactory way to extrapolate caspase-3
findings in cultured neurons and NPCs to the in vivo brain. The
in vitro findings in the established model/system in the neurons
and NPCs will require further studies to determine the in vivo
relevance.
In conclusion, we have found that the treatment with 2%
isoflurane for 6 h can induce caspase-3 activation in mice neurons
but not in mice NPCs. These data have established a model/system
to determine the up-stream mechanism by which isoflurane
induces caspase-3 activation. Moreover, we have found that the
isoflurane treatment increases the cytosol cytochrome c levels
in mice neurons but not in mice NPCs. These results have
demonstrated that we are able to use the established model/system
to investigate the underlying mechanisms of isoflurane-induced
caspase-3 activation. These findings will hopefully promote more
studies to investigate anesthesia neurotoxicity.
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